Hjem › Livmoderhalskræft › Oklahoma
Livmoderhalskræft kliniske forsøg i Oklahoma
11 studier for Livmoderhalskræft søger deltagere på steder i Oklahoma.
Byer i Oklahoma
Officiel studietekst (engelsk)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
RekruttererFase 4
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 25. sep. 2026 · NCT07216703A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07182149Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Oklahoma Health Sciences Center, Oklahoma City
- University of Oklahoma, Oklahoma City
RekruttererFrivillige med god helbredstilstand velkomne
Alder 25 og opefter · Kvinder · Opdateret 31. jul. 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Stephenson Cancer Center, Oklahoma City
Rekrutterer
Alder 18 og opefter · Kvinder · Opdateret 30. jul. 2026 · NCT04831580A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. jul. 2026 · NCT04389632A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. feb. 2026 · NCT06319963A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 7. jan. 2026 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Stephenson Cancer Center, Oklahoma City
RekruttererFase 2
Alder 18 til 99 · Kvinder · Opdateret 22. okt. 2025 · NCT05512208A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2025 · NCT05107674Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.